NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Ahmad İskandarani
Hamad Medical Corporation - Doha / Qatar
Others
AD Scientific Index ID: 4886907
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Ahmad İskandarani's MOST POPULAR ARTICLES
1-)
Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysisA Halama, M Kulinski, SS Dib, SB Zaghlool, KS Siveen, A Iskandarani, ...Cancer Letters 430, 133-147, 2018492018
2-)
Anticancer activity of camel milk via induction of autophagic death in human colorectal and breast cancer cellsR Krishnankutty, A Iskandarani, L Therachiyil, S Uddin, F Azizi, M Kulinski, ...Asian Pacific journal of cancer prevention: APJCP 19 (12), 3501, 2018392018
3-)
Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cellsKS Prabhu, KS Siveen, S Kuttikrishnan, A Iskandarani, M Tsakou, ...PLoS One 12 (7), e0180895, 2017382017
4-)
Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alphaRM El Eit, AN Iskandarani, JL Saliba, MN Jabbour, RA Mahfouz, ...International Journal of Cancer 134 (4), 988-996, 2014352014
5-)
Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cellsA Iskandarani, AA Bhat, KS Siveen, KS Prabhu, S Kuttikrishnan, MA Khan, ...Journal of Translational Medicine 14, 1-12, 2016342016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept